Loading stock data…
AdaptHealth Corp. (AHCO)
$6.49+0.07 (+1.09%)
Pre-Market$6.36-0.13 (-2.00%)· Last close Sep 4
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AdaptHealth Corp. in the Healthcare sector is trading at $6.49 with a market capitalization of $866M. Wall Street consensus targets $9.14 (7 analysts), implying a +40.9% move over the next 12 months. The stock is currently near its 52-week low of $5.21, remaining 35.0% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +40.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $567.53M↓ | $614.32M↓ | $1.47B↑ | $602.63M↑ | $492.67M |
| Gross Profit | -$68.57M↑ | -$93.98M↓ | $795.82M↑ | -$55.74M↓ | -$28.64M |
| Operating Income | $165,000↓ | $5.49M↓ | $34.14M↓ | $67.13M↑ | $33.47M |
| Net Income | -$133.93M↓ | -$16.04M↑ | -$102.77M↓ | $24.51M↑ | $14.67M |
Peer Comparison
JNJUNHPFE
Fundamentals
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$865.83M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.39
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-16.56%
Volume
Today's trading volume
2.61M
Recent News
Senior Health, Home Health & Hospice Stocks Q2 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q2.
1 Cash-Producing Stock to Consider Right Now and 2 Facing Challenges
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
3 of Wall Street’s Favorite Stocks That Fall Short
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
5 Must-Read Analyst Questions From AdaptHealth’s Q2 Earnings Call
AdaptHealth’s second quarter results prompted a significant negative market reaction, as the company reported both revenue and profitability well below Wall Street’s expectations. Management attributed this to a combination of operational inefficiencies in its large West Coast capitated contract and cost pressures from a sudden supplier price increase. CEO Suzanne Foster described the unexpected operational challenges as “not sustainable,” highlighting elevated costs from higher-than-anticipated
AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript
CEO Foster discusses West Coast operational challenges and a $30M manufacturer price increase.